McDonalds: BMO Upgrades Firm Off Back Of Strong Earnings

On July 28, McDonald’s Corp (NYSE: MCD) reported their second quarter financial results. The company reported topline revenue of $5.88 billion, growing 56.5% year over year and slightly beating the street high estimate of $5.86 billion. Gross profit came in at $3.22 billion, an increase of 86.8% year over year. The company’s gross margin was 54.7% and operating margins were 45.7% for the quarter.

Multiple analysts raised their price targets on McDonalds, bringing the 12-month average price target to $264.38, up from $258.88 before the results. The street high sits at $295 from Longbow Research and the lowest comes in at $229 from DZ bank.

BMO Capital Markets also raised their 12-month price target on McDonalds to $280, up from $265 and reiterated their outperform rating following the results. They say that McDonald’s, “continues to drive strong momentum in the US behind a sound strategy,” which includes new menu items, digital, pricing, and macro benefits. They believe that McDonalds can continue driving its growth into the coming quarter but warns that a 6% increase in pricing is not sustainable.

The company beat or came inline in all of BMO’s estimates. Mainly, earnings per share came in $0.26 higher than estimates, which reflects better same-store sales and slightly better-operating margins. BMO writes that McDonald’s “realized double-digit positive comps across all dayparts in the US in F2Q21 vs. F2Q19, while franchisees continued to achieve record-high operating cash flow,” but warns that China sales have not reached 2019 levels due to the COVID-19 situation.

McDonald’s now has 4,000 stores in China, which could provide a nice top-line tailwind for when China sales grow back or above 2019 levels. They believe that China sales will come in above 2019 numbers due to how well McDonald’s US has done.

Below you can see BMO’s updated third quarter and 2021 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

Total Metals Launches 5,500 Metre Drill Program At ElectroLode Property

Mercado Minerals Launches Two Phase Geophysical Program At Copalito Project

Related News

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Aurora Cannabis: Analysts Raise Price Targets Following Q1 Results

Yesterday, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported their first quarter 2021 results. Aurora reported...

Tuesday, November 10, 2020, 03:21:00 PM

US Cannabis: Stifel Expects “Limited To No Sales Growth”

Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the...

Monday, August 1, 2022, 01:17:00 PM

Trulieve: Canaccord Retains $97 Price Target Following Harvest Health Transaction

On October 1, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition...

Sunday, October 10, 2021, 01:03:00 PM

Cresco Labs: Canaccord Lowers Price Target To $19

Cresco Labs (CSE: CL) reported its first-quarter financial results this past week. The company announced...

Sunday, May 30, 2021, 01:07:00 PM